Re-engineering the post-myocardial infarction medicines optimisation pathway: a retrospective analysis of a joint consultant pharmacist and cardiologist clinic model
R Khatib, N Patel, U Laverty, G Mcgawley… - Open …, 2018 - openheart.bmj.com
Background Inadequate medicines optimisation and adherence are significant problems
among patients taking secondary prevention medications following myocardial infarction …
among patients taking secondary prevention medications following myocardial infarction …
Developing a post-myocardial infarction medicines optimisation clinic: core competencies for upskilling pharmacists and initial patient feedback
R Price, F Wilson, A Hall, G McGawley… - BMJ Open …, 2023 - bmjopenquality.bmj.com
Background Medicines optimisation and adherence support are essential to secondary
prevention after myocardial infarction (MI). Following successful implementation of a …
prevention after myocardial infarction (MI). Following successful implementation of a …